Catalyst Pharmaceuticals, Inc.
CPRX
$21.02
$0.150.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 276.03% | 265.65% | 110.13% | 109.39% | -53.87% |
| Total Receivables | 22.06% | 20.90% | 33.28% | 80.38% | 397.10% |
| Inventory | 24.91% | 121.55% | 67.56% | 93.19% | 129.89% |
| Prepaid Expenses | 66.01% | 31.34% | 170.92% | 89.01% | 178.58% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 193.45% | 147.09% | 465.93% | 357.31% | -28.22% |
| Total Current Assets | 184.33% | 180.70% | 96.88% | 103.41% | -31.63% |
|
|
|||||
| Total Current Assets | 184.33% | 180.70% | 96.88% | 103.41% | -31.63% |
| Net Property, Plant & Equipment | -3.21% | -2.13% | -6.40% | -6.09% | 2.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.26% | -0.65% | -0.13% | 0.34% | 497.61% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.83% | 29.51% | 69.82% | 89.09% | 95.05% |
| Total Assets | 81.11% | 86.83% | 59.13% | 58.80% | 25.15% |
|
|
|||||
| Total Accounts Payable | 12.15% | 151.48% | 60.96% | 202.60% | 272.20% |
| Total Accrued Expenses | 33.67% | 37.39% | 39.87% | 29.28% | 44.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.94% | 8.86% | 9.07% | 9.28% | 9.50% |
| Total Finance Division Other Current Liabilities | 141.77% | 132.99% | 110.83% | 30.52% | -19.01% |
| Total Other Current Liabilities | 141.77% | 132.99% | 110.83% | 30.52% | -19.01% |
| Total Current Liabilities | 58.66% | 82.33% | 75.83% | 40.31% | 32.08% |
|
|
|||||
| Total Current Liabilities | 58.66% | 82.33% | 75.83% | 40.31% | 32.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.61% | -11.97% | -11.40% | -10.87% | -10.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -89.44% | -22.10% | -81.17% | -80.53% | -78.80% |
| Total Liabilities | 50.52% | 71.77% | 42.42% | 15.90% | 9.34% |
|
|
|||||
| Common Stock & APIC | 65.95% | 64.71% | 64.02% | 63.98% | 6.41% |
| Retained Earnings | 135.14% | 165.22% | 58.15% | 81.98% | 143.22% |
| Treasury Stock & Other | 357.14% | -- | -- | -- | -41.67% |
| Total Common Equity | 87.59% | 89.63% | 62.18% | 68.26% | 29.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 87.59% | 89.63% | 62.18% | 68.26% | 29.11% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 87.59% | 89.63% | 62.18% | 68.26% | 29.11% |
|
|
|||||
